Mainz, Germany, 12-12-2013 — /EuropaWire/ — The Energiepark Mainz, planned for the Hechtsheim district of the city of Mainz, can go ahead, with construction set to start in the spring of 2014. This has today been confirmed by Siemens, the Linde Group, … Read the full press release
Novartis supplies MenB vaccine for a vaccination program at Princeton, following approvals by health authorities and University officials Bexsero, already licensed in Europe, Australia and Canada, is the only broad coverage vaccine to help protect against MenB disease MenB is … Read the full press release
In two Phase III studies, Jakavi ® reduced the risk of death and maintained spleen reductions at three years compared to conventional therapy and placebo Similar survival benefit seen in patients with and without high-risk mutations Separate analysis shows Jakavi may increase … Read the full press release
Guildford, UK / Munich, Germany, 12-12-2013 — /EuropaWire/ — Capture Power Limited, the consortium of Alstom, Drax and BOC, today welcomed the UK Government’s announcement that it has been awarded a Front End Engineering and Design (FEED) contract for its planned, state-of-the-art … Read the full press release
Posted in Energy, Gas & Oil, Environment, Germany, Government, Infrastructure & Utilities, United Kingdom
Tagged Alstom, Biomass, BOC, Capture Power, carbon capture and storage, carbon dioxide storage, carbon dioxide transportation, CCS power plant, coal, consortium, Drax, Edward Davey, FEED contract award, Leigh Hackett, National Grid Carbon Limited, North Yorkshire, Peter Boreham, Selby, The Linde Group, UK Government, White Rose CCS Project, Yorkshire Humber CCS Trunkline
ENESTnd data indicate trend for longer overall survival and event-free survival in newly diagnosed Ph+ CML patients on Tasigna versus Glivec[1] Data demonstrated higher rates of early and deeper molecular response in newly diagnosed patients, including MR4.5, and a reduced … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Switzerland
Tagged Giuseppe Saglio, Glivec®, imatinib, leukemia, nilotinib, Novartis, Novartis's Tasigna®, Ph+ CML, Phase III studies
Walldorf, Germany, 12-12-2013 — /EuropaWire/ — SAP AG (NYSE: SAP) today announced that it has been ranked by Forrester Research Inc. as a leader in its report “The Forrester Wave™: Enterprise Data Warehouse, Q4 2013.”* In the evaluation, SAP earned among the highest scores among … Read the full press release
Posted in Business, Germany, Internet & Online, Technology
Tagged Cathrin von Osten, EDW vendors, Enterprise Data Warehouse Solutions, Forrester Research Inc, Franz Faerber, Jeff Neal, leader, Q4 2013”, REPORT, Samantha Finnegan, SAP AG, SAP HANA®, SAP® Sybase® IQ, “The Forrester Wave™: Enterprise Data Warehouse
New OpenUI5, a New Unified Developer License, Node.js Connector and a New Development Environment for SAP HANA Create More Opportunities Bangalore, India, 12-12-2013 — /EuropaWire/ — SAP AG (NYSE: SAP) today announced an extended and deeper commitment to the developer community with … Read the full press release
Posted in Business, Germany, Internet & Online, Technology
Tagged Bangalore, INDIA, Node.js Connector, open source, OpenUI5, SAP AG, SAP HANA®, SAPUI5, SAP® TechEd
Athens, Greece, 12-12-2013 — /EuropaWire/ — Alpha Bank (hereinafter the “Bank”) announces that, based on the Warrant exercise orders submitted until 10.12.2013, 28.8 million Warrants on shares issued by the Bank and owned by the Hellenic Financial Stability Fund (“Warrants”) have been blocked … Read the full press release
Walldorf, Germany, 12-12-2013 — /EuropaWire/ — Reaffirming its commitment to provide independent companies and subsidiaries worldwide a flexible, cost-effective mid-market cloud enterprise resource planning (ERP) suite, SAP AG (NYSE: SAP) today announced new capabilities for the SAP Business ByDesign® solution. The updates leverage SAP … Read the full press release
Sofia, Bulgaria, 12-12-2013 — /EuropaWire/ — From 13 December 2013, the Bulgarian National Bank releases in circulation a copper commemorative coin ‘90 Years since the Birth of Apostol Karamitev’ from the series ’Bulgarian Artists’. It will be sold at the BNB teller … Read the full press release
For media outside of the US, the UK & Canada only The efficacy and safety profile of Pradaxa® (dabigatran etexilate) was maintained regardless of patient characteristics1,2,3,4 Pooled safety data favour Pradaxa® treatment over warfarin and provide further reassurance1-4 The analysed … Read the full press release
Sofia, Bulgaria, 12-12-2013 — /EuropaWire/ — Today, in compliance with article 1, paragraph 2 and article 50 of the Law on the Bulgarian National Bank, the BNB Report for the first half of 2013 and the BNB budget for 2014 were presented … Read the full press release
“Industry on Campus” as part of the Excellence Initiative – application-oriented research for better vision Tübingen, Germany, 12-12-2013 — /EuropaWire/ — More than four billion people all over the world are reliant on ophthalmic or medical devices to enable them to optimally … Read the full press release
Milan, Italy, 12-12-2013 — /EuropaWire/ — Today, A2A has successfully placed on the European market a 500 million Euro bond due on January 13, 2022, under its 3 billion Euro Medium Term Notes Programme updated and increased on November 25, 2013. The … Read the full press release
Milan, Italy, 12-12-2013 — /EuropaWire/ — Today, A2A has successfully privately placed a 300 million Euro tenyear bond under its 3 billion Euro Medium Term Notes Programme approved and increased by the Management Board of A2A on November 7, 2013. The private … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
